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Prevention of mother-to-child Transmission and HIV Treatment programmes were scaled-up in resource-constrained settings
over a decade ago, but there is still much to be understood about women’s experiences of living with HIV and their HIV
disclosure patterns. This qualitative study explored women’s experiences of living with HIV, 6–10 years after being
diagnosed during pregnancy. The area has high HIV prevalence, and an established HIV treatment programme. Participants
were enrolled in a larger intervention, “Amagugu”, that supported women (n = 281) to disclose their HIV status to their
children. Post-intervention we conducted individual in-depth interviews with 20 randomly selected women, stratified by
clinic catchment area, from the total sample. Interviews were entered into ATLAS.ti computer software for coding. Most
women were living with their current sexual partner and half were still in a relationship with the child’s biological father.
Household exposure to HIV was high with the majority of women knowing at least one other HIV-infected adult in their
household. Eighteen women had disclosed their HIV status to another person; nine had disclosed to their current partner
first. Two main themes were identified in the analyses: living with HIV and the normalisation of HIV treatment at a family
level; and the complexity of love relationships, in particular in long-term partnerships. A decade on, most women were
living positively with HIV, accessing care, and reported experiencing little stigma. However, as HIV became normalised new
challenges arose including concerns about access to quality care, and the need for family-centred care. Women’s sexual
choices and relationships were intertwined with feelings of love, loyalty and trust and the important supportive role played
by partners and families was acknowledged, however, some aspects of living with HIV presented challenges including
continuing to practise safe sex several years after HIV diagnosis.
Keywords: maternal HIV disclosure; partnerships; HIV treatment; stigma; family
Introduction
Successful prevention of mother-to-child-transmission
(PMTCT) and HIV treatment programmes have reduced
mortality and resulted in HIV-positive women living
longer to care for their children who are mostly HIV-
uninfected (WHO, 2013). Keeping women alive is bene-
ficial for children, and associated with decreased child
mortality in highly prevalent HIV settings (Ndirangu,
Newell, Tanser, Herbst, & Bland, 2010; Ndirangu, Newell,
Thorne, & Bland, 2012).
Much is known about the clinical health of HIV-
infected women in resource-constrained settings (Coutsou-
dis et al., 2010; Miiro et al., 2009), however, less is known
about their experiences of living with HIV several years
after their diagnosis, and to whom they have disclosed.
Emerging literature on HIV disclosure describes both
positive and negative outcomes following disclosure;
increased social support has been reported (Bouillon et al.,
2007; Groves, Maman, & Moodley, 2012; Maman et al.,
2003) violence and abandonment have also been docu-
mented (Linda, 2013; Medley, Garcia-Moreno, McGill, &
Maman, 2004). There is a dearth of evidence from
longitudinal research in African settings to inform adher-
ence support programmes (Bärnighausen, Tanser, Dabis, &
Newell, 2012; Dewing et al., 2012; Santer, Ring, Yardley,
Geraghty, & Wyke, 2014) and limited data on client
perspectives of antiretroviral treatment (ART) services
(Orner et al., 2008).
This qualitative study explores the experiences of 20
HIV-infected women, who learnt their HIV diagnosis
during pregnancy as participants in the Vertical Transmis-
sion Study (VTS; 2001–2006), rural South Africa (Bland,
Coovadia, Coutsoudis, Rollins, & Newell, 2010; Coovadia
et al., 2007; Mkwanazi et al., 2008). It explores their
experiences of living with HIV and taking ART, their
partnerships and issues of access and equity to treatment.
Methods
The setting
This study was conducted in northern KwaZulu-Natal, at
the Africa Centre for Health and Population Studies
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(www.africacentre.com). The setting is rural, resource-
limited and predominantly Zulu speaking (Bärnighausen,
Tanser, Malaza, Herbst, & Newell, 2012; Tanser
et al., 2008).
In 2001 the Department of Health, in partnership
with the Africa Centre, launched a PMTCT programme
and, in keeping with policy at the time, single-dose
Nevirapine was offered to HIV-infected women during
labour, and their infants post-partum. Since then PMTCT
regimens have changed, and now all HIV-infected
pregnant women, not already on treatment, receive
ART at their first antenatal visit (WHO, 2013). Since
2004 an HIV Programme has provided free HIV
treatment and care in a devolved programme at primary
health care clinics in the area (Bland & Ndirangu, 2013;
Houlihan et al., 2010; Janssen, Ndirangu, Newell, &
Bland, 2010). Initially, the eligibility criteria for ART
was a CD4 cell count of ≤200 cells/ml, but since 2014
has been extended to include all those with a CD4 cell
count of ≤500 cells/ml (WHO, 2013).
Measures
This qualitative study was undertaken with a sub-sample
of women who had participated in two intervention
studies, one to support exclusive breastfeeding to reduce
vertical transmission of HIV (“VTS”; Bland et al., 2010)
and the other to support maternal HIV disclosure
(“Amagugu”; Rochat, Arteche, Stein, Mkwanazi, &
Bland, 2014). The aim of this qualitative research was to
better understand women’s experiences of living with HIV
over a long period of time, and to explore their
experiences of participating in the VTS and Amagugu
interventions. A two-part interview guide was developed:
Part One was open-ended and explored women’s experi-
ences of being HIV-infected since their diagnosis in the
VTS and is the subject of this manuscript. Part Two
focused on their experiences of participating in the
Amagugu intervention, the subject of a separate analysis.
The interview started with an open-ended narrative and
then included topic area probes. The open-ended question
was: “Tell me about your life since we last saw you in the
VTS”. Through these interviews we sought to address less
understood psychosocial topics about women of child-
bearing age, highlighted in the literature, including HIV
testing during pregnancy, safe sex negotiations and
experiences of living with HIV (McGrath, Richter, &
Newell, 2013; Rochat et al., 2006; Varga, Sherman, &
Jones, 2006). The probes explored the following:
(1) Women’s experiences of access to HIV care and
treatment.
(2) Women’s experiences of their sexual partner-
ships since the VTS.
Sample
HIV-infected women included in these analyses were a
sub-sample of participants enrolled in the Amagugu
study, who had received support to disclose their HIV
status to their 6- to 10-year-old child (Rochat, Mkwa-
nazi, & Bland, 2013; Rochat et al., 2014). Women had
first been tested for HIV in the local PMTCT programme
and had known their HIV status for at least six years
(Mkwanazi et al., 2008). The Amagugu disclosure
intervention targeted the VTS index child specifically,
but mothers were encouraged to disclose their status to
their other children post-intervention. Resources and
time available determined the initial sample size and
we purposefully selected 20 participants from five of the
nine clinic areas in which the Amagugu study operated,
representing urban and rural settings. After completion
of the 20 interviews a preliminary round of data analysis
was undertaken and it was concluded that saturation had
been reached.
Data collection
Socio-demographic and disclosure data were collected
during a baseline survey in the Amagugu intervention.
Two months after completing the intervention one of the
researchers (NM) contacted the sample of women by
telephone, explained the qualitative study and requested
an appointment to conduct individual in-depth interview;
all 20 women agreed to participate and provided written,
informed, consent.
Data preparation and analysis
The in-depth interviews lasted approximately 60 minutes
at the women’s homes were tape recorded, transcribed
verbatim and translated from isiZulu to English by NM.
All interviews were read several times for familiarity
with the data and the transcripts were entered into
ATLAS.ti computer software for coding of common
themes (Friese, 2012). NM analysed the interviews by
category to determine common elements, patterns and
themes within each participant’s interview. These were
coded and compared across interviews to determine
dominant thematic areas within the content areas. To
ensure researcher reflexivity, NM, who is herself a Zulu
woman, kept detailed daily notes of personal reactions
to, and reflections on, interview content, which might
inform interpretation bias. Transcripts were then inde-
pendently reviewed by the second author (TJ) after
which all three authors reviewed the results to reach
consensus on the most salient themes, their organisation
and to explore aspects of researcher reflexivity.
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AIDS Care
Results
The characteristics of participating women are shown in
Table 1. Their median age was 32 years (IQR 29–37);
their children’s median age was seven years (IQR 6.5–
7.5). Of the five women reported as married, two were
legally married and three were engaged; of those
reported as unmarried (n = 14), 12 had current partners
and approximately half were living with their current
partner. HIV exposure in the households was high with
most women (n = 14) reporting that another adult family
member was HIV-infected. The majority of women were
on ART (n = 14), with a median CD4 cell count of 430
(IQR 310–554) cells/ml; one woman eligible for treat-
ment had not accessed ART.
Table 2 presents people to whom the women had
disclosed their HIV status. More than half had disclosed
to their current partners (n = 13), half of whom were also
HIV-infected. Two women had not disclosed to anyone
due to fear of HIV-related stigma.
In total, the 20 women had 56 biological children,
aged 2–18 years, of whom 43 were reported to have been
tested for HIV and were HIV negative. One mother
reported that she had disclosed her HIV status to her 12-
year-old, HIV negative, child, a sibling of the study
child, prior to the intervention. Post-intervention, all
mothers had disclosed to their study children – 10 fully
(i.e., explained they had HIV) and 10 partially (i.e.,
explained they had a “virus” of whom six mothers
subsequently fully disclosed).
In data analysis two main themes emerged:
(1) Living with HIV and normalising ART.
(2) Love, partnerships and sex.
Theme 1: Living with HIV and normalizing ART
At the time of diagnosis, HIV testing had recently been
introduced into the study area, and HIV prevalence
amongst pregnant women was high (approximately
40%). This led to suspicion or disbelief about a positive
HIV test, for the women and some of their families:
You know when you are at the clinic and you are
checking and you ask one another: “How come we all
are found to be infected?” They must be playing with us.
You don’t pay attention to anything. When you suffer
from things such as headaches then you start paying
attention. (29-year-old)
However, given the increased access to ART in the years
following the VTS, the majority of women shared
experiences of living positively with HIV. Availability
of ART was considered a privilege previously denied to
many, and this changed how women perceived HIV:
At home we were eight, now only four are left. My sister
left a 9 month old child who is now 16 years old. So,
Table 1. Characteristics of the 20 women that were interviewed.
Study
Number
Maternal
age
(years)
Child
age
(years)
Child
sex
Marital
status
PMTCT
Site
Currently
employed
Bore child
after
index child
Last CD4 cell
count result
cells/ml
Currently
on ART
1 26 7 F Single Peri-urban No Yes 105 Yes
2 32 6 M Single Peri-urban No Yes 568 Yes
3 32 7 F Single Rural Yes Yes 379 Noa
4 44 8 M Single Peri-urban Yes No 800 Yes
5 46 7 M Married Peri-urban No No 700 Yes
6 36 6 F Married Peri-urban Yes No 297 Yes
7 37 7 M Single Rural No No 487 Yes
8 49 8 F Widowed Rural No No 219 Yes
9 28 6 F Single Rural No No 212 Yes
10 39 8 F Married Rural Yes No 467 Yes
11 28 7 F Single Rural No Yes 629 No
12 32 7 M Married Rural No Yes 518 Yes
13 37 7 M Single Rural No Yes 400 Yes
14 38 6 F Married Rural Yes Yes 350 Yes
15 31 8 F Single Rural No Yes 709 No
16 36 7 F Single Rural Yes Yes 459 No
17 28 6 F Single Rural No Yes 300 Yes
18 29 8 M Single Rural Yes Yes 320 No*
19 32 7 F Single Rural No No 540 No
20 29 7 F Single Rural No Yes 394 Yes
aAt the time of the interview ART eligibility criteria was ≤350 cells/ml.
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Table 2. HIV disclosure of participating women.
Study
number
In a relationship
with the child’s
father
Lives with
current
partner
Partner
HIV
positive
Aware of other adult
family members
with HIV
Disclosed to
current
partner
Disclosed
to parent
Disclosed
to sibling
Disclosed
to friend
Disclosed to
other
relative
Disclosed to
religious
person
Whom
disclosed
to first
1 No No No Yes No No No No Yes No Partner
2 No No No Yes Yes Yes Yes Yes Yes Yes Parent
3 No Yes Yes Yes No No No No No No No
disclosure
4 Yes Yes Yes Yes Yes No No No Yes No Partner
5 Yes Yes No No Yes Yes Yes Yes Yes Yes Parent
6 Yes Yes Yes Yes Yes Yes No Yes No No Partner
7 No Yes No Yes Yes No Yes Yes Yes No Sibling
8 Yes No Yes Yes Yes No Yes No Yes Yes Partner
9 No No Yes Yes Yes No Yes Yes No No Sibling
10 Yes Yes Yes Yes Yes No Yes Yes Yes No Friend
11 No No No No Yes No Yes Yes No No Friend
12 Yes Yes No Yes Yes No Yes Yes Yes No Partner
13 Yes No No Yes No No No No No No No
disclosure
14 Yes No No No Yes No No Yes No No Partner
15 Yes No No No No No No No No No Partner
16 Yes Yes Yes Yes Yes No No No No No Partner
17 No No No Yes No Yes No No No No Parent
18 No No No Yes No No No Yes Yes Yes Other
relative
19 No No No No No No No No Yes No Other
relative
20 No Yes Yes No Yes Yes Yes Yes Yes No Partner
Total 10 9 8 14 13 5 9 11 11 4
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AIDS Care
when we take pills [ART] now, we are taking them for
the reason that we had siblings who died without getting
help. Children were left without parents. I have survived,
and now free pills are available. (46-year-old)
Most women were taking ART, regularly attending ART
clinics and knew other HIV-infected people, which
helped to reduce stigma:
Sometimes you see others hiding by the corners when
they attend HIV clinics, I do no such [thing]! People are
taking their own pills for BP [blood pressure problems],
arthritis, why? They want to live. I’m taking ARVs
[antiretroviral drugs] because I want to live. If we all die,
the tomb does not say this one was killed by AIDS, this
one was killed by BP. We are all dead! When I go to the
clinic I even strut my stuff. I don’t care that ARVs have
made me have thin legs and flat buttocks, eish!
[Laughter]. (46-year-old)
There was a sense of HIV causing a chronic, rather than
fatal, illness and pride rather than shame in going to HIV
clinics:
Most of my neighbours are open now; we even lend
each other pills. They come and say we have come to
borrow our “teabag”. I was counting that I have been
taking ARVs for 10 years. We are going to push my
husband in a wheel barrow [when he gets sick] because
he does not want to test. (46-year-old)
As women settled into longer term HIV care they
became increasingly concerned about the quality of
health services and understanding more about their
illness. Women described becoming selective about
ART clinics based either on the quality of care received,
or on being able to attend the same clinic as a partner:
I also want to change from Clinic A to Clinic B, they are
not safe there. They sometimes give you pills that are
not enough. They are careless. I go to Clinic B because
my partner also took his ARVs there and sometimes we
can walk to town together. (26-year old)
Some women expressed confusion over the clinical
course of HIV infection, and were perplexed about the
relationship between CD4 counts and their physical
health:
I just started ARVs six months ago. When I checked I
discovered that my CD4 count was 112. I was beyond
shocked, I can’t explain it. I was dead walking. I felt
fine. I realised that is why people just drop dead. (37-
year-old)
Theme 2: Love, partnerships and sex
All women agreed that partnerships were complex and
discordant HIV results presented particular difficulties:
He showed me his negative results. I thought how can
I show him my positive result? I told my sister my fear
was if I say I’m positive he will say I am the one who
brought the virus. We discussed with my sister that we
have to plan how we are going to tell him because he has
to be protected and we should not practise unsafe sex.
(37-year-old)
When I disclosed, he did not want to accept it. He did
not fight me though; I think it is because he knows of his
ways. We continued getting other children. I also do not
want to lie; when I discovered my HIV status, it was not
such an issue. (29-year-old)
Women reported that some partners were accepting of
their HIV status, and supportive, despite discordant
results:
I am a kind of a person that discloses everything. I always
have my ARVs with me, openly. I’m visiting here but
I have them openly with my cosmetics. When I disclosed
to my partner he said: “I wonder how you got it”. I said
maybe I have had too many children, maybe I was
helping someone. He did not fight with me. He said he
was also going to go to the clinic to test and he did. He
goes every six months and is negative. Maybe he has
strong soldiers [CD4 cells] because they cannot detect it
[HIV]. I tell him he will end up starting treatment or
he will just fall and die but we are using condoms.
(32-year-old)
Some partners provided finances for women’s children,
although they were not the biological fathers. While this
made the partner more attractive, it also complicated
disclosure due to women’s fears of abandonment:
… on Thursday he said let’s go and see “o-small” [the
small ones, my children not his] and we first went to the
shop. I thought we were just buying snacks but he said:
“Don’t they eat? Take rice”. And we packed the trolley
and took the stuff to them. So, when you have such
people you don’t want to spoil things and you think this
is my last chance if I do not use it I will not find
someone like him. (32-year-old)
Despite knowing about safe sex, women articulated that
they were not consistent with condom use, talking about
their own weaknesses, rather than male coercion which
is often reported in the literature:
Sometimes there are things that make you weak and
your resistance crumbles. Sometimes it happens that
someone judges you and they think this one is fine she
has nothing. That mistake happens sometimes, I don’t
want to lie but it’s not an everyday mistake, I try to
avoid it. I try to be strict. (29-year-old)
Discussion
This qualitative study adds to the literature about the
lives of rural, African, women living with HIV, including
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their disclosure patterns (Stevens & Galvao, 2007; Varga
et al., 2006). We found high levels of stability in
partnerships with half the women still in a relationship
with the biological father of the child, only two of whom
had not disclosed to them. Approximately half the
women had disclosed to their partners first and their
broader family network subsequently, suggesting that
stability of partnerships (reflected by duration and co-
residency) is an important facilitator of partner disclos-
ure, as documented in the literature (Alemayehu, Aregay,
Kalayu, & Yebyo, 2014; Antelman et al., 2001; Bacha-
nas et al., 2013; Mayfield Arnold, Rice, Flannery, &
Rotheram-Borus, 2008; Medley et al., 2004). Our
finding that partners were generally described as being
supportive is similar to findings from other parts of
Africa and Asia (Deribe, Woldemichael, Wondafrash,
Haile, & Amberbir, 2008; Medley et al., 2004; Skuno-
dom et al., 2006). Importantly, for many women HIV
disclosure did not necessarily facilitate low risk beha-
viours, raising questions about the support couples might
need beyond the disclosure itself. The 2012 WHO
Couple Counselling Guidelines highlights that couple
counselling has not received programmatic attention
especially in situations of HIV sero-discordance (WHO,
2012), and studies have shown that couple counselling
support has an important role in facilitating long-term
ART adherence (Anglemyer, Horvath, & Rutherford,
2013; Brown et al., 2011).
High HIV prevalence rates in the study area, and the
political climate during women’s diagnosis at pregnancy,
led to suspicion about the existence of HIV, but women
reported gradual acceptance of HIV as a chronic illness.
In the early years of the epidemic there was significant
focus on stigma and its impact on testing, however, this
research suggests that, with increased access to treat-
ment, stigma is reduced (Maman et al., 2009), and most
women were living positively with HIV and taking ART
without fear. However, as they stabilised on ART their
needs changed and they expressed new concerns includ-
ing quality of health care and counselling support. With
large numbers of people attending HIV clinics, counsel-
lors are often trained to give generic information to
everyone to maximise efficiency, and seldom have time
to address individual concerns or for health promotion.
Counselling training curricula need to evolve to include
issues such discordant results in relationships (Dworkin
& Ehrhardt, 2007), the challenges of living with a
chronic disease and ART adherence (Rochat, Bland,
Coovadia, Stein, & Newell, 2011). Offering family-
centred, rather than individual, care may hold particular
advantages for women and their families in high
prevalence settings (Betancourt, Abrams, McBain, &
Fawzi, 2010; Kairania et al., 2010; Richter, 2010).
To date literature on gender and HIV has often
portrayed men as determinants of women’s HIV risk
(Dunkle et al., 2004; Greig, Peacock, Jewkes, &
Msimang, 2008), and while this is mostly correct, the
contribution of this research is important as it presents a
more assertive, women’s voice, with women gaining
autonomy over their health through access to care, and
the ability to make decisions about their sexual health.
The vast majority of research supporting a particularly
gendered perspective on risk is cross-sectional rather
than longitudinal, and may, by its design, preclude a
clear understanding of how women’s power and inde-
pendence in relationships may change over time in stable
partnerships. This research highlights that sexual health
resides within love relationships which are complex, and
it is this complexity that informs the decisions women
make in relation to HIV care.
Conclusion
The wide-scale roll-out of HIV prevention and treatment
programmes have brought about considerable changes
for women who are now surviving to parent children in a
society that has less HIV-related stigma. However, the
transition to longer term care raises new challenges,
including securing quality family-centred care and deal-
ing with disclosure in new sexual partnerships. The
narratives of this group of women contribute to under-
standing the challenges of African HIV-positive women
of childbearing age in the ART era.
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